Segment Information (Tables)

3 Months Ended

Apr. 01, 2022

Segment Reporting [Abstract]

Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

Revenue, gross profit, gross profit margin, operating income (loss), and depreciation and amortization expenses by reportable segment were as follows (in thousands, except percentage data):

	Three Months Ended
	April 1,		April 2,
Revenue	2022		2021
Photonics	$	62,782	$	58,493
Vision		62,050		67,636
Precision Motion		79,384		36,455
Total	$	204,216	$	162,584

	Three Months Ended
	April 1,			April 2,
Gross Profit	2022			2021
Photonics	$	28,387		$	28,109
Vision		25,230			26,926
Precision Motion		38,150			16,077
Unallocated Corporate and Shared Services		(1,491	)		(2,372	)
Total	$	90,276		$	68,740

	Three Months Ended
	April 1,			April 2,
Gross Profit Margin	2022			2021
Photonics		45.2	%		48.1	%
Vision		40.7	%		39.8	%
Precision Motion		48.1	%		44.1	%
Total		44.2	%		42.3	%

	Three Months Ended
	April 1,			April 2,
Operating Income (Loss)	2022			2021
Photonics	$	13,435		$	12,395
Vision		5,042			3,366
Precision Motion		18,338			7,446
Unallocated Corporate and Shared Services		(12,532	)		(12,108	)
Total	$	24,283		$	11,099

	Three Months Ended
	April 1,		April 2,
Depreciation and Amortization Expenses	2022		2021
Photonics	$	2,777	$	2,898
Vision		4,427		5,275
Precision Motion		6,737		1,607
Unallocated Corporate and Shared Services		103		69
Total	$	14,044	$	9,849

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

	Three Months Ended
	April 1,		April 2,
	2022		2021
United States	$	82,715	$	59,230
Germany		31,778		22,363
Rest of Europe		33,373		35,575
China		26,799		22,551
Rest of Asia-Pacific		22,840		20,747
Other		6,711		2,118
Total	$	204,216	$	162,584

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Three Months Ended
	April 1,			April 2,
	2022			2021
Medical		47	%		55	%
Advanced Industrial		53	%		45	%
Total		100	%		100	%